Subcutaneous immunoglobulin therapy has become a routine in the treatment of antibody deficiency and it is an important therapeutic option. It is an alternative to intravenous treatment that allows patients to administer their therapy independently in a non-clinical environment. IgSC as Gammanorm® gives patients freedom and independence from hospital treatment. IgSC is highly appreciated by patients and can improve their quality of life.
With IgSC, patients control their own therapy and are able to:
- Integrate therapy into their daily routine.
- Reduce the frequency of hospital visits.
- Integrate therapy into their daily routine.
- Organize work or pleasure trips without having to go to the hospital.